Etravirine

Results: 47



#Item
211  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EDURANT® safely and effectively. See full prescribing information for EDURANT.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-12-10 17:41:28
221  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

Add to Reading List

Source URL: www.intelence.com

Language: English - Date: 2014-08-26 13:35:32
23HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. VIRAMUNE® (nevirapine) tablets, for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIRAMUNE safely and effectively. See full prescribing information for VIRAMUNE. VIRAMUNE® (nevirapine) tablets, for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-01-28 14:06:56
24Imprimer  Effacer DEMANDE D’AUTORISATION DE PAIEMENT Enfuvirtide (FuzeonMC), Étravirine (IntelenceMC), Maraviroc (CelsentriMC),

Imprimer Effacer DEMANDE D’AUTORISATION DE PAIEMENT Enfuvirtide (FuzeonMC), Étravirine (IntelenceMC), Maraviroc (CelsentriMC),

Add to Reading List

Source URL: www.ramq.gouv.qc.ca

Language: French - Date: 2014-07-21 11:01:45
    25Supplements 11, 12, & 14 draft labeling  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for IN

    Supplements 11, 12, & 14 draft labeling HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for IN

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2013-03-01 14:46:34
    26Global HIV Access & Partnerships Program GAPP Status: Branded Registration Efforts AT JANSSEN, a comprehensive, multi-country registration effort ensures timely availability of our branded HIV medicines where there is a

    Global HIV Access & Partnerships Program GAPP Status: Branded Registration Efforts AT JANSSEN, a comprehensive, multi-country registration effort ensures timely availability of our branded HIV medicines where there is a

    Add to Reading List

    Source URL: www.janssenrnd.com

    Language: English - Date: 2012-07-18 12:13:42
    271  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

    1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE® safely and effectively. See full prescribing information for INTELENCE®.

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-08-15 16:02:38
    28etravirine – [removed]Final Labeling Text  HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE™ safely and effectively. See full prescribing information for

    etravirine – [removed]Final Labeling Text HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INTELENCE™ safely and effectively. See full prescribing information for

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2009-10-06 17:32:52
    2922187 Etravirine Clinical PREA

    22187 Etravirine Clinical PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    3022187 Etravirine Clinpharm PREA

    22187 Etravirine Clinpharm PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English